Brief: Todos Says All 31 Patients In COVID-19 Treatment Trial Have Completed Study Participation
02/12/2021 11:38
Dec 2 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL ANNOUNCES ALL 31 PATIENTS ENROLLED TO DATE
IN
TOLLOVIR® PHASE 2 CLINICAL TRIAL IN HOSPITALIZED COVID-19
PATIENTS HAVE COMPLETED STUDY PARTICIPATION
Source text for Eikon: ID:nGNXbfcJFt
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities